ADUS vs NRIX: Which Stock Is the Better Buy?
Addus HomeCare Corporation and Nurix Therapeutics, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — ADUS vs NRIX, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Addus HomeCare Corporation (ADUS) | Nurix Therapeutics, Inc. (NRIX) | |
|---|---|---|
| Market cap | $1.7B | $1.7B |
| Revenue (latest FY) | $1.42B | $83.98M |
| Net income (latest FY) | $95.91M | $-264.46M |
| Revenue growth (5y CAGR) | 13.2% | 36.3% |
| Net margin | 6.7% | -314.9% |
| Return on equity | 8.8% | -49.1% |
| P/E ratio | 17.1 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 10 | 0 |
| Positive free cash flow | Yes | No |
Verify the comparison
Use the filing period and source shown by each tool before treating two figures as comparable.
See the full ADUS vs NRIX breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open ADUS's full financials → Open NRIX's full financials →More comparisons
Frequently asked questions
Which is bigger, ADUS or NRIX?
Nurix Therapeutics, Inc. is larger by market capitalization — $1.7B versus $1.7B.
Which grows faster, ADUS or NRIX?
Over the last five fiscal years, Nurix Therapeutics, Inc. grew revenue faster — 36.3%/yr versus 13.2%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
ADUS fundamentals → · NRIX fundamentals → · All 1,500+ companies → · Free screener →